Next Issue
Volume 4, March
Previous Issue
Volume 3, September
 
 

Dermato, Volume 3, Issue 4 (December 2023) – 3 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
4 pages, 1161 KiB  
Case Report
Adenosquamous Carcinoma of the Skin: A Case Report
by Rim Jridi, Franziska Hartmann, Stefanie Boms, Andrea Tannapfel and Thilo Gambichler
Dermato 2023, 3(4), 263-266; https://doi.org/10.3390/dermato3040020 - 13 Dec 2023
Viewed by 913
Abstract
Adenosquamous carcinoma of the skin (ASCS) or primary cutaneous adenosquamous carcinoma is a rare malignant neoplasm. It is characterized by the presence of both glandular and squamous cell components and a propensity for aggressive clinical behavior. Due to its rarity, it continues to [...] Read more.
Adenosquamous carcinoma of the skin (ASCS) or primary cutaneous adenosquamous carcinoma is a rare malignant neoplasm. It is characterized by the presence of both glandular and squamous cell components and a propensity for aggressive clinical behavior. Due to its rarity, it continues to pose diagnostic challenges. To date, only a few cases of this tumor have been reported, and even fewer have been thoroughly investigated via immunohistochemistry. Full article
(This article belongs to the Special Issue What Is Your Diagnosis?—Case Report Collection)
Show Figures

Figure 1

22 pages, 2292 KiB  
Review
Rosacea: An Overview of Its Etiological Factors, Pathogenesis, Classification and Therapy Options
by Serap Maden
Dermato 2023, 3(4), 241-262; https://doi.org/10.3390/dermato3040019 - 01 Nov 2023
Cited by 2 | Viewed by 2766
Abstract
Rosacea is a common chronic inflammatory skin condition. It mainly affects the cheeks, nose, chin, and forehead, causing flushing or transient erythema, persistent erythema, phymatous changes, papules, pustules, and telangiectasias, and the eyes may also be affected by rosacea. Rosacea is more common [...] Read more.
Rosacea is a common chronic inflammatory skin condition. It mainly affects the cheeks, nose, chin, and forehead, causing flushing or transient erythema, persistent erythema, phymatous changes, papules, pustules, and telangiectasias, and the eyes may also be affected by rosacea. Rosacea is more common in women than in men and can start at any age. Rosacea affects both fair-skinned and darker-skinned people. Physical changes in the face due to rosacea can cause embarrassment, leading to reduced quality of life and self-esteem. Rosacea has several triggers, and its pathogenesis involves multiple factors, which means there are several treatment options, and these options can be combined. A patient’s clinical findings and symptoms will help a doctor to diagnose and classify the condition. Treatment options may include lifestyle changes, topical medications, systemic antibiotics and light-based therapy. The best approach is to tailor the treatment to the individual’s condition and preferences. The aim of treatment is to manage symptoms and prevent the progression of the disease. Full article
Show Figures

Figure 1

9 pages, 2088 KiB  
Case Report
A Case of Paraneoplastic Anti-TIF1-γ Antibody-Positive Dermatomyositis Presenting with Generalized Edema and Associated with Aortic Aneurysm
by Raven Bennett, Katherine Bradley, Iman Salem, David Weiner, Dhrumil Patel, Jeffrey Cloutier, Nicole Pace and Dorothea Barton
Dermato 2023, 3(4), 232-240; https://doi.org/10.3390/dermato3040018 - 18 Oct 2023
Viewed by 1280
Abstract
Dermatomyositis (DM) is a rare autoimmune inflammatory disease characterized by pathognomonic skin findings, often accompanied by myositis beginning with proximal weakness [...] Full article
Show Figures

Figure 1

Previous Issue
Next Issue
Back to TopTop